Table 2. Clinical categorization of hMPV-positive patients in the present study sample.
Clinical categorization | Total no. (%) | hMPV mono-infection (n=21) | hMPV co-infection (n=5) |
|
---|---|---|---|---|
Upper respiratory tract infection | 14 (53.84) | 12 (57.14) | 2 (40) | |
LRTI | Bronchiolitis | 2 (7.69) | 1 (4.76) | 1 (20) |
Bronchopneumonia | 8 (30.77) | 6 (23.07) | 2 (40) | |
Severe infection with mortality* | 2 (7.69) | 2 (9.52) | 0 |
*Both patients were adults and severely immunocompromised following chemotherapy.